Towarzystwo Funduszy Inwestycyjnych PZU SA’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
2,361
+261
+12% +$79.2K 0.29% 55
2026
Q1
$449K Sell
2,100
-375
-15% -$83.8K 0.15% 107
2025
Q4
$424K Buy
2,475
+15
+0.6% +$2.33K 0.11% 119
2025
Q3
$329K Sell
2,460
-190
-7% -$20.1K 0.08% 126
2025
Q2
$258K Buy
2,650
+200
+8% +$15.9K 0.07% 128
2025
Q1
$178K Hold
2,450
0.06% 149
2024
Q4
$177K Buy
2,450
+300
+14% +$22.8K 0.06% 138
2024
Q3
$175K Buy
2,150
+250
+13% +$21.7K 0.06% 132
2024
Q2
$202K Buy
1,900
+200
+12% +$19.2K 0.08% 112
2024
Q1
$165K Hold
1,700
0.07% 126
2023
Q4
$133K Buy
+1,700
New +$116K 0.06% 134
2021
Q3
$34.1K Hold
600
0.04% 176
2021
Q2
$39K Hold
600
0.05% 164
2021
Q1
$35.7K Hold
600
0.05% 155
2020
Q4
$28.3K Buy
+600
New +$25.2K 0.03% 165

Other funds holding LRCX

Towarzystwo Funduszy Inwestycyjnych PZU SA's LRCX Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA increased its Lam Research (LRCX) stake by 12% in Q2 2026, buying an estimated $79.2K and bringing the position to 2,361 shares worth $1.02M. The position accounts for 0.29% of the portfolio, ranked #55.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in LRCX in Q4 2020 and has held it in 15 quarters since. 2,425 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Towarzystwo Funduszy Inwestycyjnych PZU SA held 2,361 shares of Lam Research worth $1.02M as of Q2 2026.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA bought 261 Lam Research shares in Q2 2026, an estimated $79.2K.
  • Lam Research made up 0.29% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #55 holding.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in Lam Research in Q4 2020 and has held it in 15 quarters since.
  • 2,425 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.